Clinical Trials
- Thyroid and Other Endocrine Cancers, Pancreatic Cancer
Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors
- Endocrine System, Genetics
A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease (GATEWAY)
- Ages18 years - 60 years
- GenderBoth
- Endocrine System, Genetics
VX-121 Combination Therapy in Subjects With Cystic Fibrosis VX20-121-103
- Ages12 years and older
- GenderBoth
- Thyroid and Other Endocrine Cancers
Phase 1b/3 Global, Randomized, Controlled, Open-label Trial Comparing Treatment With RYZ101 to Standard of Care Therapy in Subjects With Inoperable, Advanced, SSTR+, Well-differentiated GEP-NETs That Have Progressed Following Prior 177Lu-SSA Therapy
- Thyroid and Other Endocrine Cancers, Gynecological Cancers
Endometrium and Metabolism
- Lung Cancer, Breast Cancer
A Study to Investigate LYL797 in Adults With Solid Tumors
- Endocrine System
Sight-saving Engagement and Evaluation in New Haven (SEEN) Program
- Endocrine System
Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis
- Ages18 years - 80 years
- GenderBoth
- Children's Health, Endocrine System, Genetics, Mental Health & Behavioral Research
Yale Center for Clinical Investigation (YCCI) Specimen and Data Repository
- Ages7 years - 70 years
- GenderBoth
- Pancreatic Cancer
Phase II Randomized, Prospective Trial of Lutetium Lu 177 Dotatate PRRT Versus Capecitabine and Temozolomide in Well-Differentiated Pancreatic Neuroendocrine Tumors